Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Med Genet ; 49(1): 93-100, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16473316

RESUMEN

We present a case of opsismodysplasia, a very rare skeletal dysplasia, in a term newborn female who had short length, short extremities and markedly short fingers. Radiological studies demonstrated severe platyspondyly, absence of epiphyseal ossification centers, short tubular bones, especially severe in hands and feet, with metaphyseal cupping. She also had hydrocephaly, a rare finding in opsismodysplasia. In our literature review we have found 24 cases, 17 born alive and seven terminations of pregnancy (TOPs).


Asunto(s)
Anomalías Múltiples/diagnóstico , Enfermedades del Desarrollo Óseo/genética , Hidrocefalia/etiología , Enfermedades del Desarrollo Óseo/congénito , Enfermedades del Desarrollo Óseo/diagnóstico , Enfermedades del Desarrollo Óseo/patología , Femenino , Genes Recesivos , Deformidades Congénitas de la Mano/genética , Humanos , Recién Nacido , Deformidades Congénitas de las Extremidades/genética , Masculino , Anomalías Musculoesqueléticas/genética
2.
Pediatrics ; 111(5 Pt 1): 1002-9, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12728080

RESUMEN

OBJECTIVE: The aim of our study was to evaluate the effect of zinc supplementation on linear growth, body composition, and growth factors in premature infants. DESIGN: Thirty-six preterm infants (gestational age: 32.0 +/- 2.1 weeks, birth weight: 1704 +/- 364 g) participated in a longitudinal double-blind, randomized clinical trial. They were randomly allocated either to the supplemental (S) group fed with a standard term formula supplemented with zinc (final content 10 mg/L) and a small quantity of copper (final content 0.6 mg/L), or to the placebo group fed with the same formula without supplementation (final content of zinc: 5 mg/L and copper: 0.4 mg/L), from 36 weeks postconceptional age until 6 months corrected postnatal age. At each evaluation, anthropometric variables and bioelectrical impedance were measured, a 3-day dietary record was collected, and a blood sample was taken. We analyzed serum levels of total alkaline phosphatase, skeletal alkaline phosphatase (sALP), insulin growth factor (IGF)-I, IGF binding protein-3, IGF binding protein-1, zinc and copper, and the concentrations of zinc in erythrocytes. RESULTS: The S group had significantly higher zinc levels in serum and erythrocytes and lower serum copper levels with respect to the placebo group. We found that the S group had a greater linear growth (from baseline to 3 months corrected age: Delta score deviation standard length: 1.32 +/-.8 vs.38 +/-.8). The increase in total body water and in serum levels of sALP was also significantly higher in the S group (total body water: 3 months; corrected age: 3.8 +/-.5 vs 3.5 +/-.4 kg, 6 months; corrected age: 4.5 +/-.5 vs 4.2 +/-.4 kg; sALP: 3 months; corrected age: 140.2 +/- 28.7 vs 118.7 +/- 18.8 micro g/L). CONCLUSIONS: Zinc supplementation has a positive effect on linear growth in premature infants.


Asunto(s)
Composición Corporal/efectos de los fármacos , Suplementos Dietéticos , Sustancias de Crecimiento/metabolismo , Recien Nacido Prematuro/crecimiento & desarrollo , Recien Nacido Prematuro/metabolismo , Sulfato de Zinc/administración & dosificación , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/metabolismo , Antropometría , Sulfato de Cobre/administración & dosificación , Sulfato de Cobre/sangre , Proteínas en la Dieta/metabolismo , Método Doble Ciego , Impedancia Eléctrica , Ingestión de Energía/efectos de los fármacos , Femenino , Sustancias de Crecimiento/sangre , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro/sangre , Estudios Longitudinales , Masculino , Sulfato de Zinc/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA